Profusa, Inc. (PFSA)
| Market Cap | 18.48M |
| Revenue (ttm) | 75,000 |
| Net Income (ttm) | -9.56M |
| Shares Out | 33.00M |
| EPS (ttm) | -1.71 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,748,726 |
| Open | 0.5407 |
| Previous Close | 0.4900 |
| Day's Range | 0.4915 - 0.6330 |
| 52-Week Range | 0.4561 - 5.5000 |
| Beta | -0.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About PFSA
Profusa, Inc. develops bioengineered sensors that are designed to become one with the body to detect and continuously transmit clinical -grade data for personal and medical use. The company was incorporated in 2009 and is based in Emeryville, California. [Read more]
Financial Performance
In 2024, Profusa's revenue was $100,000, an increase of 122.22% compared to the previous year's $45,000. Losses were -$9.23 million, -10.22% less than in 2023.
Financial StatementsNews
Profusa, Inc. Provides Strategy Overview and Business Update for Investors
BERKELEY, Calif, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology pla...
Profusa Secures Lumee™ Oxygen Platform Distributor in Spain
BERKELEY, Calif, July 31, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology pla...
Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy
BERKELEY, Calif, July 21, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology pla...
Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq
Profusa's Common Stock is Expected to Begin Trading on Nasdaq on Monday, July 14, 2025 Under the Ticker "PFSA" BERKELEY, Calif, July 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Compa...